A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/18/2004	US20040229794 Lipophilic drug delivery vehicle and methods of use thereof
11/18/2004	US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
11/18/2004	US20040229791 Modulating activity of growth factor in sample which contains an activated alpha 2-macroglobulin by contacting sample with fatty acid to inhibit formation of a complex between growth factor and activated alpha 2-macroglobulin, wherein the fatty acid binds to the activated alpha 2-macroglobulin
11/18/2004	US20040229790 Substance having an activity which modulates or inhibits proliferation of AILIM(activation inducible lymphocyte immunomodulatory molecule)-expressing cells or production of a cytokine; for treatment of rheumatoid arthritis, osteoarthritis
11/18/2004	US20040229781 Drug screening for agents to treat cardiovascular disorders; use of drug JTV-519, a member of the 1,4 benzothiazepine family of compounds, to repair leak in ryanodine receptor RyR2 channels
11/18/2004	US20040229778 Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
11/18/2004	US20040229776 Pharmaceutical compositions for hepatitis C viral protease inhibitors
11/18/2004	US20040229773 Methods and compositions for increasing the anaerobic working capacity in tissues
11/18/2004	US20040229771 administering a product containing reduced amount of carbohydrate-derived toxins or a product capable of removing or reducing such toxins upon administration; products nclude various dialysis fluids, particularly peritoneal dialysis fluids, and food or nutritional fluids
11/18/2004	US20040229339 Comprises neisseria membrane protein for use as tool in generation of vaccine to prevent infection and sepsis in infants
11/18/2004	US20040229317 Nucleotide sequences coding amino acid transport protein for use in identifying modulator for treatment of cell proliferative and tissue distribution disorders
11/18/2004	US20040229300 Zinc-based screening test and kit for early diagnosis of prostate cancer
11/18/2004	US20040229296 Restoring cellular energy levels and treating cell proliferation disorders
11/18/2004	US20040229294 Using epidermal growth factor receptor complexes to diagnose and prognose health in cancer patients; drug screening
11/18/2004	US20040229285 Treating neurotransmitter dysfunction using amino acid precursors which enhance serotonin and catecholamine concentration
11/18/2004	US20040229277 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229266 RNA interference mediating small RNA molecules
11/18/2004	US20040229265 Amino-modified polysaccharides and methods of generating and using same
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040229232 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040228936 Administering cocoa extracts including procyanidin monomers and oligomers to treat inflammation, atherosclerosis, and cardiovascular disorders; bactericides, foods; cyclooxygenase and/or lipoxygenase inhibitors
11/18/2004	US20040228935 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction
11/18/2004	US20040228934 Compositions and methods of use for extracts of magnoliaceae plants
11/18/2004	US20040228933 Method for normalizing insulin levels
11/18/2004	US20040228928 Method of altering, enhancing and standardizing the potency and bioactivity of bioactive polysaccharides
11/18/2004	US20040228924 Pharmaceutical products
11/18/2004	US20040228923 Pulmonary delivery in treating disorders of the central nervous system
11/18/2004	US20040228921 Compositions and methods for delivery of therapeutic agents
11/18/2004	US20040228917 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
11/18/2004	US20040228916 Spray coating insoluble drug particles dissolved in a plasticizer with a solvent-free, powdered enteric coating agent; improved bioavailability and solubility; pollution control
11/18/2004	US20040228915 coated core particles of clindamycin are overcoated with a binder-dispersing agent, such as povidone; streptococci, pneumococci, and staphylococci infections
11/18/2004	US20040228914 Formulation
11/18/2004	US20040228912 Once daily formulations of tetracyclines
11/18/2004	US20040228911 Vinorelbine compositions and methods of use
11/18/2004	US20040228910 Transdermal, oral and intravenous formulations of 2, 3-dimethoxy-5-methyl-6-decaprenyl-1, 4-benzoquinone
11/18/2004	US20040228909 Compositions and methods for treating lymphoma
11/18/2004	US20040228907 R(-)N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane; neuronal rescue or protection; immunostimulant; oral or transdermal administration; Attention Deficit Disorder
11/18/2004	US20040228906 Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence
11/18/2004	US20040228903 Soft drink replacer
11/18/2004	US20040228894 Cosmetic compositions
11/18/2004	US20040228889 Use of N-arylmethylene ethylenediaminetriacetates, N-arylmethylene iminodiacetated or N,N'-diarylmethylene ethylenediamineacetates as doners of NO
11/18/2004	US20040228884 Ion-pair delivery system for cosmetic and pharmaceutical compositions
11/18/2004	US20040228883 Prepackaged aqueous pharmaceutical formulation for the treatment of cardiac conditions containing at least two different active agents and method of formulation
11/18/2004	US20040228881 Compositions and methods for modulating neural sprouting
11/18/2004	US20040228879 Streptococcus pneumoniae polysaccharide is conjugated to protein or peptide, and RSV antigen with adjuvant which is stimmulator of (cytotoxic T) lymphocytes
11/18/2004	US20040228876 Composition and Method for Treating Cancer Using Herpes Virus
11/18/2004	US20040228860 Antibodies to a tumor-associated surface antigen for delivery of diagnostic and therapeutic agents
11/18/2004	US20040228830 Multiparticulate compositions of milnacipran for oral administration
11/18/2004	US20040228823 for drug delivery, particularly in cancer as a tumor-specific delivery system
11/18/2004	US20040228808 Inhaling formulation providing analgesia to patient; contains one rapid-onset opioid and a sustained-effect opioid; avoiding toxicity while achieving analgesia, side effect occurs before the onset of toxicity; dispensers
11/18/2004	US20040228807 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone
11/18/2004	US20040228806 For use in therapy of chronic obstructive pulmonary disease and asthma; an inhalette capsule contains a mixture of coarser and fine excipient particles
11/18/2004	US20040228804 Preventing the occurrence of respiratory infections, shipping fever during shipping the cattles, by misting the nose with a solution containing adonitol
11/18/2004	US20040228803 Sleeve and micro-encapsulated topical analgesic for pain relief
11/18/2004	US20040228802 Dosage forms when the drug is properly administered, free of bitter taste, no coloring; when administering not follow the instructions, crushed or extracted and nasally, orally, buccally or sublingually administered, drug will taste bitter, forming color to stain human tissue
11/18/2004	US20040226852 Method of stabilizing azithromycin
11/18/2004	DE4124409B4 Pharmazeutische Zubereitungen Pharmaceutical preparations
11/18/2004	DE10319808A1 Use of carboxy-substituted polysaccharides, such as carboxy cellulose or carboxymethyl cellulose, for stimulating cell proliferation e.g. to treat wounds
11/18/2004	DE10319592A1 Behandlung von diabetischer Retinopathie mit Angiotensin II-Rezeptorblockern Treatment of diabetic retinopathy with angiotensin II receptor blockers
11/18/2004	DE10319450A1 Pharmazeutische Formulierung des Telmisartan Natriumsalzes The pharmaceutical formulation of telmisartan sodium salt
11/18/2004	DE10318714A1 Wirkstoff-Kombination und Therapien zur Bekämpfung des Alkoholmissbrauchs Drug combination therapies to combat alcohol abuse
11/18/2004	DE10315917A1 Hochreine Basen von 3,3-Diphenylpropylaminmonoestern High purity bases of 3,3-Diphenylpropylaminmonoestern
11/18/2004	DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions
11/18/2004	DE102004014005A1 Pharmazeutische Zusammensetzung zur Prophylaxe oder Behandlung von Osteoporose und Verfahren zu deren Herstellung A pharmaceutical composition for prophylaxis or treatment of osteoporosis and processes for their preparation
11/18/2004	CA2526875A1 Carbacephem beta-lactam antibiotics
11/18/2004	CA2525325A1 Pyrazole-amides and sulfonamides as sodium channel modulators
11/18/2004	CA2525302A1 Multivalent inhibitors of serum amyloid p component
11/18/2004	CA2525298A1 Methods of treating ischemic related conditions
11/18/2004	CA2525195A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
11/18/2004	CA2525190A1 Intermediate compound which is used for the preparation of pioglitazone
11/18/2004	CA2524904A1 Combination of a glycine/nmda antagonist and a tachykinin nk-1 receptor antagonist for use in the treatment of neurodegeneration
11/18/2004	CA2524894A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them
11/18/2004	CA2524891A1 Ultraviolet-shielding type patch
11/18/2004	CA2524889A1 1,2-diarylimidazoles useful as inhibitors of cox
11/18/2004	CA2524773A1 Particulate coformulations of active substances with excipients
11/18/2004	CA2524682A1 Use of sulphonamide derivatives for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion
11/18/2004	CA2524625A1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
11/18/2004	CA2524624A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004	CA2524622A1 Substituted-1-phthalazinamines as vr-1 antagonists
11/18/2004	CA2524610A1 Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
11/18/2004	CA2524603A1 Controlled release composition containing a strontium salt
11/18/2004	CA2524593A1 Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract
11/18/2004	CA2524519A1 Compounds as crf1 receptor antagonists
11/18/2004	CA2524474A1 Methods of hormonal treatment utilizing extended cycle contraceptive regimens
11/18/2004	CA2524469A1 Method, apparatus, and composition for treating acne
11/18/2004	CA2524397A1 Cannabinoid receptor ligands and uses thereof
11/18/2004	CA2524368A1 Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide
11/18/2004	CA2524324A1 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhibitors
11/18/2004	CA2524321A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	CA2524318A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/18/2004	CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524268A1 Proton pump inhibitors for the treatment of lower abdominal disorders
11/18/2004	CA2524267A1 Heat activated tertiary amine urethane catalysts
11/18/2004	CA2524260A1 Process of making press molded materials using heat activated tertiary amine urethane catalysts
11/18/2004	CA2524235A1 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2524221A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004	CA2524172A1 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
11/18/2004	CA2524166A1 Medical devices and methods for inhibiting proliferation of smooth muscle cells
11/18/2004	CA2524161A1 Pyridinyl acetonitriles

1 ... 4888 4889 4890 4891 4892 4893 4894 4895 4896 4897 4898 4899 4900 4901 4902 4903 4904 4905 4906 4907 4908 ... 7860